Healthcare cost by primary tumour, functioning status and treatment among patients with metastatic neuroendocrine tumours: The LyREMeNET study-Reference-Cited by-同舟云学术

Healthcare cost by primary tumour, functioning status and treatment among patients with metastatic neuroendocrine tumours: The LyREMeNET study

Published:2022-01-25 Issue:4 Volume:34 Page:
ISSN:0953-8194
Container-title:Journal of Neuroendocrinology
language:en
Short-container-title:J Neuroendocrinology

Author:

Perrier Marine¹^ORCID,Polazzi Stéphanie²³,Lemelin Annie¹,Fernandez Violaine²³,Labonne Stéphanie¹,Maucort‐Boulch Delphine⁴⁵,Lombard‐Bohas Catherine¹,Duclos Antoine²³⁵,Walter Thomas¹⁵

Affiliation:

1. Service de Gastroentérologie et d’Oncologie Médicale Hospices Civils de Lyon Hôpital Edouard Herriot Lyon France

2. Service des Données de Santé Hospices Civils de Lyon Lyon France

3. Research on Healthcare Performance lab INSERM U1290 RESHAPE Université Claude Bernard Lyon 1 Lyon France

4. Service de Biostatistique Laboratoire de Biométrie et Biologie Evolutive Equipe Biostatistique‐Santé Hospices Civils de Lyon Université Lyon 1 Lyon France

5. Lyon 1 Claude Bernard University Lyon France

Funder

Ipsen

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience,Endocrine and Autonomic Systems,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jne.13092

Reference19 articles.

1. Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States

2. Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

3. Economics of gastroenteropancreatic neuroendocrine tumors: a systematic review

4. Costs of Cancer Care for Elderly Patients with Neuroendocrine Tumors

5. Cost-of-illness of metastatic gastroenteropancreatic neuroendocrine tumours in Sweden-A population-based register-linkage study

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Computing the Cost of Care per Patient per Day for Patients With Metastatic Neuroendocrine Neoplasms;JCO Oncology Practice;2023-12-14

2. Assessment of the Role of Leptin and Adiponectinas Biomarkers in Pancreatic Neuroendocrine Neoplasms;Cancers;2023-07-06

3. A practical proposal on treatment sequencing of metastatic well-differentiated neuroendocrine tumours;Therapeutic Advances in Medical Oncology;2023-01